The path to commercial success: Novel approaches toward cancer neoantigen vaccines. Shape the future of next generation cancer vaccine development with new oncolytic approaches and critical immunotherapy strategies
Click here to register!
Attend our presentation
Market Trends and Why Is There No Vaccine Available?
Time: 2:05pm EST
Day: February 2, 2023
- Jeffrey Bockman, PhD, EVP, BioConsulting, Head of Oncology, Lumanity
- Erik Digman Wiklund, CEO, Targovax
- Why is there no commercially available vaccination ready on the market?
- Current market trends of cancer vaccines – why are they gaining popularity now?
- A look to the future